Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Bivalirudin Infusion For Ventricular Infarction Limitation
Author(s): Robert-Jan van Geuns Added: 6 years ago
Robert-Jan van Geuns from Erasmus Medical Centre, Rotterdam, The Netherlands disusses BIVAL: Bivalirudin infusion for ventricular infarction limitation: the BIVAL study. Filmed by Radcliffe Cardiology on-site at EuroPCR 2017. View more

Anticoagulation

Intervention
Author(s): Emanuela de Cillis , Giuseppe Sangiorgi , Alessandro Santo Bortone Added: 3 years ago
Bleeding and vascular complications related to invasive cardiovascular procedures are associated with significant morbidity and mortality. Indeed, the most common complications resulting from cardiac catheterisation are vascular-related, including external bleeding at the arterial puncture site, ecchymosis, retroperitoneal haematoma and pseudoaneurysms. As guidelines recommend that the patient… View more

Anticoagulation

Vascular Disease and Surgery
Anticoagulant Therapy for Acute Coronary Syndromes
Author(s): Eunice NC Onwordi , Amr Gamal , Azfar Zaman Added: 3 years ago
Acute coronary syndromes (ACS) are a major cause of morbidity and mortality. Despite the use of optimal medical therapy and revascularisation there remains a significant risk of vascular events. Registry data indicates a persistent risk even in patients who are event free in the first year following ACS, with as many as 1 in 5 patients suffering a vascular event in the subsequent 3 years.1 The… View more

Anticoagulation

Prevention & Chronic Conditions
Author(s): Benjamin Galper , Roxana Mehran Added: 3 years ago
Acute coronary syndromes (ACS) result from unstable coronary artery plaques that rupture and can lead to coronary ischaemia, unstable angina and myocardial infarction. The treatment goals in ACS focus on reducing ischaemia, preventing further progression of thrombotic plaque by disturbing the milieu of thrombosis and platelet aggregation taking place within the coronary artery and, in the case of… View more

Anticoagulation

Standards & Guidelines
Author(s): Sri Raveen Kandan , Thomas W Johnson Added: 3 years ago
Antiplatelet Therapy Current guidelines support the early administration of oral antiplatelet agents upstream of angiographic assessment and intervention.1 Aspirin is commonly given by the first medical contact and additional oral antiplatelet drugs are administered on arrival in hospital (see Figure 1). Aspirin The efficacy of aspirin in acute ST-segment elevation myocardial infarction (STEMI)… View more

Anticoagulation
Author(s): Steven V Manoukian , Michele D Voeltz , Frederick Feit Added: 3 years ago
Non-ST-segment elevation (NSTE) acute coronary syndromes (ACS) include unstable angina (UA) and NSTE myocardial infarction (NSTEMI), and account for one and a half million hospitalisations in the US annually. Patients with ACS are typically managed by initial medical stabilisation followed by an early invasive approach, whereby cardiac catheterisation is performed, usually within 24 hours of… View more

Anticoagulation

Imaging & Diagnostics
Author(s): Bruce R Brodie Added: 3 years ago
Abstract This article reviews optimum therapies for the management of ST-elevation myocardial infarction (STEMI) with primary percutaneous coronary intervention (PCI). Optimum anti-thrombotic therapy includes aspirin, bivalirudin and the new anti-platelet agents prasugrel or ticagrelor. Stent thrombosis (ST) has been a major concern but can be reduced by achieving optimal stent deployment, use… View more

Vascular Disease and Surgery

Prevention & Chronic Conditions
Author(s): Georgios J Vlachojannis , Bimmer E Claessen , George D Dangas Added: 3 years ago
Platelet adhesion, activation and aggregation play key roles in the initiation of intracoronary thrombosis that causes acute coronary syndromes (ACS) and ischaemic complications following coronary artery interventions, including recurrent myocardial infarction (MI) and stent thrombosis (ST). Indeed, the most feared complication related to coronary stent placement is ST. ST might occur after… View more

MI/ACS

Intervention
Author(s): Fizzah A Choudry , Roshan P Weerackody , Daniel A Jones , et al Added: 3 years ago
Over the last few decades, primary percutaneous coronary intervention (PCI) has revolutionised the treatment of ST-elevation myocardial infarction (STEMI) with rapid recanalisation of the infarct-related epicardial vessel, resulting in smaller infarct size and a substantial reduction in adverse clinical endpoints.1,2 However, suboptimal myocardial reperfusion is documented to occur in a… View more

Intervention
Stefan James
Job title: Professor of Cardiology
Prof Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital in Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC.He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has… View more